Controversy over the benefits of screening for breast cancer and prostate cancer hit the headlines and the blogosphere when the New York Times reported on Oct. 21 that the American Cancer Society was planning to temper its proscreening message for breast and prostate cancers, and a prominent representative of the society denied it on his blog.
PREVIEW